Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Novartis
NVS
$287B
| $5.27M | ﹤0.01% |
62,395
+58,105
| +1,354% | +$5.1M |
|
|
DTP
3602
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| $5.27M | ﹤0.01% |
+102,277
| New | +$5.34M |
|
3603
PUT
Exelon
EXC
$47.2B
| $5.27M | ﹤0.01% |
116,300
+41,700
| +56% | +$1.96M |
|
3604
PUT
iShares Core S&P Small-Cap ETF
IJR
$114B
| $5.27M | ﹤0.01% |
57,000
-55,600
| -49% | -$5.53M |
|
3605
CALL
ProShares UltraPro Short Dow 30
SDOW
$186M
| $5.27M | ﹤0.01% |
35,581
+19,350
| +119% | +$2.53M |
|
|
MTOR
3606
DELISTED
MERITOR, Inc.
MTOR
| $5.26M | ﹤0.01% |
144,885
-88,996
| -38% | -$3.2M |
|
3607
CALL
Brookfield
BN
$107B
| $5.26M | ﹤0.01% |
219,456
+166,389
| +314% | +$4.45M |
|
3608
Brink's
BCO
$4.71B
| $5.26M | ﹤0.01% |
+86,617
| New | +$5.22M |
|
3609
PUT
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $5.26M | ﹤0.01% |
159,900
+52,800
| +49% | +$1.79M |
|
3610
PUT
Canadian Imperial Bank of Commerce
CM
$113B
| $5.26M | ﹤0.01% |
108,300
-175,100
| -62% | -$9.53M |
|
3611
Merit Medical Systems
MMSI
$5.42B
| $5.25M | ﹤0.01% |
96,772
-37,866
| -28% | -$2.31M |
|
3612
NRG Energy
NRG
$26.5B
| $5.25M | ﹤0.01% |
137,582
-266,202
| -66% | -$10.9M |
|
3613
Bally's
BALY
$685M
| $5.25M | ﹤0.01% |
265,452
+109,283
| +70% | +$2.83M |
|
3614
AXIS Capital
AXS
$7.38B
| $5.25M | ﹤0.01% |
91,956
+87,231
| +1,846% | +$4.97M |
|
3615
CALL
Sunoco
SUN
$14.2B
| $5.25M | ﹤0.01% |
140,900
+67,200
| +91% | +$2.73M |
|
|
KIII
3616
DELISTED
Kismet Acquisition Three Corp. Class A Ordinary Shares
KIII
| $5.25M | ﹤0.01% |
535,495
+1,636
| +0.3% | +$16K |
|
3617
CALL
PACCAR
PCAR
$68.8B
| $5.24M | ﹤0.01% |
95,400
-13,800
| -13% | -$777K |
|
3618
CALL
ATI
ATI
$31.1B
| $5.23M | ﹤0.01% |
230,400
+90,000
| +64% | +$2.37M |
|
3619
CALL
First Majestic Silver
AG
$9.49B
| $5.22M | ﹤0.01% |
727,400
-407,700
| -36% | -$3.98M |
|
3620
Insteel Industries
IIIN
$631M
| $5.21M | ﹤0.01% |
154,789
+137,320
| +786% | +$5.46M |
|
|
RADI
3621
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $5.21M | ﹤0.01% |
341,480
+105,663
| +45% | +$1.52M |
|
|
NOVA
3622
DELISTED
Sunnova Energy
NOVA
| $5.2M | ﹤0.01% |
282,003
-1,073,989
| -79% | -$20.5M |
|
3623
CareDx
CDNA
$2.34B
| $5.2M | ﹤0.01% |
241,882
+48,514
| +25% | +$1.35M |
|
|
PMT
3624
PennyMac Mortgage Investment
PMT
$824M
| $5.19M | ﹤0.01% |
375,591
-36,517
| -9% | -$557K |
|
3625
PUT
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$329M
| $5.19M | ﹤0.01% |
19,467
+6,820
| +54% | +$1.55M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.